Literature DB >> 11739237

Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation.

C Canetti1, J S Silva, S H Ferreira, F Q Cunha.   

Abstract

1. We investigated the mediators responsible for neutrophil migration induced by ovalbumin (OVA) in immunized mice and the mechanisms involved in their release. 2. OVA administration promoted dose- and time-dependent neutrophil migration in immunized, but not in non-immunized mice, which was mediated by leukotriene B(4) (LTB(4)) and tumour necrosis factor (TNF)alpha, since it was inhibited by LTB(4) synthesis inhibitor (MK 886) or by LTB(4) receptor antagonist (CP 105,696), by dexamethasone and by antiserum to TNFalpha (82, 85, 63 and 87%, respectively). Confirming TNFalpha involvement, OVA challenge in immunized p55 TNF receptor deficient mice (p55(-/-)) did not promote neutrophil migration (control: 2.90 +/- 0.68; p55(-/-): 0.92+/-0.23 x 10(6) neutrophils cavity(-1)). 3. OVA-stimulated peritoneal cells from immunized mice released a neutrophil chemotactic factor which mimicked, in naive mice, neutrophil migration induced by OVA. 4. Supernatant chemotactic activity is due to TNFalpha and LTB(4), since its release was inhibited by MK 886 (93%) and dexamethasone (90%), and significant amounts of these mediators were detected. 5. TNFalpha and LTB(4) released by OVA challenge seem to act through a sequential mechanism, since MK 886 inhibited (88%) neutrophil migration induced by TNFalpha. Moreover, peritoneal cells stimulated with TNFalpha released LTB(4). 6. CD(4)(+) T cells are responsible for TNFalpha release, because the depletion of this subset prevented the release of TNFalpha (control: 400 +/- 25; immunized: 670 +/- 40; CD(4)(+) depleted: 435 +/- 18 pg ml(-1)). 7. In conclusion, neutrophil migration induced by OVA depends on TNFalpha released by CD(4)(+) cells, which acts through an LTB(4)-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739237      PMCID: PMC1572894          DOI: 10.1038/sj.bjp.0704403

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Assay of pyrogens by interleukin-6 release from monocytic cell lines.

Authors:  Y S Taktak; S Selkirk; A F Bristow; A Carpenter; C Ball; B Rafferty; S Poole
Journal:  J Pharm Pharmacol       Date:  1991-08       Impact factor: 3.765

2.  PAF antagonists do not modify IgE antibody production in mice.

Authors:  S Jancar; Y Riffo-Vasquez; A P Ferreira; M S Macedo
Journal:  Braz J Med Biol Res       Date:  1991       Impact factor: 2.590

3.  (+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model.

Authors:  K Koch; L S Melvin; L A Reiter; M S Biggers; H J Showell; R J Griffiths; E R Pettipher; J B Cheng; A J Milici; R Breslow
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

Review 4.  Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts.

Authors:  G S Panayi; V M Corrigall; C Pitzalis
Journal:  Rheum Dis Clin North Am       Date:  2001-05       Impact factor: 2.670

5.  Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.

Authors:  J A Rankin; I Sylvester; S Smith; T Yoshimura; E J Leonard
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Rapid up-regulation of CXC chemokines in the airways after Ag-specific CD4+ T cell activation.

Authors:  P G Knott; P R Gater; P J Dunford; M E Fuentes; C P Bertrand
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.

Authors:  H J Showell; E R Pettipher; J B Cheng; R Breslow; M J Conklyn; C A Farrell; G P Hingorani; E D Salter; B C Hackman; D J Wimberly
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

8.  Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis.

Authors:  Y Zhang; B F Ramos; B A Jakschik
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

Review 9.  Rheumatoid arthritis. The role of neutrophil activation.

Authors:  G Weissmann; H Korchak
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

10.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.

Authors:  R Malaviya; T Ikeda; E Ross; S N Abraham
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

View more
  27 in total

1.  Proposal to use pentoxifylline and Lyprinol therapy for chronic inflammatory diseases.

Authors:  S H Ferreira
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Inflammatory mechanisms underlying the rat pulmonary neutrophil influx induced by airway exposure to staphylococcal enterotoxin type A.

Authors:  Ivani A Desouza; Carla F Franco-Penteado; Enilton A Camargo; Carmen S P Lima; Simone A Teixeira; Marcelo N Muscará; Gilberto De Nucci; Edson Antunes
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  The role of the LTB4-BLT1 axis in chemotactic gradient sensing and directed leukocyte migration.

Authors:  Bhagawat C Subramanian; Ritankar Majumdar; Carole A Parent
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

4.  Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice.

Authors:  Waldiceu A Verri; Thiago M Cunha; Danilo A Magro; Ana T G Guerrero; Silvio M Vieira; Vanessa Carregaro; Guilherme R Souza; Maria das Graças M O Henriques; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

5.  Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fabiano Oliveira; Gabriele C Rodrigues; Marcia W Carneiro; Kiyoshi F Fukutani; Fernanda O Novais; José Carlos Miranda; Manoel Barral-Netto; Claudia Brodskyn; Aldina Barral; Camila I de Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

6.  Analgesic and anti-inflammatory studies of cyclopeptide alkaloid fraction of leaves of Ziziyphus nummularia.

Authors:  Manoj Goyal; Manik Ghosh; B P Nagori; D Sasmal
Journal:  Saudi J Biol Sci       Date:  2013-10       Impact factor: 4.219

7.  A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.

Authors:  S M Vieira; H P Lemos; R Grespan; M H Napimoga; D Dal-Secco; A Freitas; T M Cunha; W A Verri; D A Souza-Junior; M C Jamur; K S Fernandes; C Oliver; J S Silva; M M Teixeira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

8.  The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats.

Authors:  Joice Maria Cunha; Daniela Sachs; Cláudio Azevedo Canetti; Stephen Poole; Sérgio Henrique Ferreira; Fernando Queiroz Cunha
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.

Authors:  Caroline Bélanger; Hanan Elimam; Julie Lefebvre; Pierre Borgeat; Sylvie Marleau
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

10.  PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.

Authors:  Alexandre Trifilieff; Anne Bench; Marcus Hanley; Debbie Bayley; Emma Campbell; Paul Whittaker
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.